EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders

Fábio Duarte, Gabriel Vachey, Nicholas S Caron, Melanie Sipion, Maria Rey, Anselme L Perrier, Michael R Hayden iD, Nicole Déglon iD

Human Gene Therapy · 2023

DOI: 10.1089/hum.2023.109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, 2023. Verfasst von Fábio Duarte und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Neurotherapies, Department of Clinical Neurosciences (DNC). Hauptthemen laut MEDLINE: Central Nervous System Diseases, Huntington Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a toxic gain-of-function CAG expansion in the first exon of the huntingtin (HTT) gene. The monogenic nature of HD makes mutant HTT (mHTT) inactivation a promising therapeutic strategy. Single nucleotide polymorphisms frequently associated with CAG expansion have been explored to selectively inactivate mHTT allele using the CRISPR/Cas9 system. One of such allele-selective approaches consists of excising a region flanking the first exon of mHTT by inducing simultaneous double-strand breaks at upstream and downstream positions of the mHTT exon 1. The removal of the first exon of mHTT deletes the CAG expansion and important transcription regulatory sites, leading to mHTT inactivation. However, the frequency of deletion events is yet to be quantified either in vitro or in vivo. Here, we developed accurate quantitative digital polymerase chain reaction-based assays to assess HTT exon 1 deletion in vitro and in fully humanized HU97/18 mice. Our results demonstrate that dual-single guide RNA (sgRNA) strategies are efficient and that 67% of HTT editing events are leading to exon 1 deletion in HEK293T cells. In contrast, these sgRNA actively cleaved HTT in HU97/18 mice, but most editing events do not lead to exon 1 deletion (10% exon 1 deletion). We also showed that the in vivo editing pattern is not affected by CAG expansion but may potentially be due to the presence of multiple copies of wildtype (wt)/mHTT genes HU97/18 mice as well as the slow kinetics of AAV-mediated CRISPR/Cas9 delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System DiseasesHuntington DiseaseHumansAnimalsMiceRNA, Guide, CRISPR-Cas SystemsHEK293 CellsExonsAllelesCentral Nervous System

Stichwörter der Autor:innen

Huntington's diseaseSNPallele-selectivegene editinghaplotypes

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Neurotherapies, Department of Clinical Neurosciences (DNC).
  • Laboratory of Cellular and Molecular Neurotherapies (LCMN), Neuroscience Research Center (CRN); Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Centre for Molecular Medicine and Therapeutics, BC Children's Hospital and Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Université Paris-Saclay, CEA, CNRS, Laboratoire des Maladies Neurodégénératives: mécanismes, thérapies, imagerie, Fontenay-aux-Roses, France.
  • Université Paris-Saclay, CEA, Molecular Imaging Research Center, Fontenay-aux-Roses, France.

ORCID-Profile: Michael R Hayden, Nicole Déglon

Zitieren

APA

Duarte, F., Vachey, G., Caron, N. S., Sipion, M., Rey, M., Perrier, A. L., Hayden, M. R., & Déglon, N. (2023). Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders. Human Gene Therapy. https://doi.org/10.1089/hum.2023.109

Vancouver

Duarte F, Vachey G, Caron NS, Sipion M, Rey M, Perrier AL, et al. Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders. Human Gene Therapy. 2023. doi:10.1089/hum.2023.109

BibTeX
@article{Duarte2023,
  author = {Duarte, Fábio and Vachey, Gabriel and Caron, Nicholas S and Sipion, Melanie and Rey, Maria and Perrier, Anselme L and Hayden, Michael R and Déglon, Nicole},
  title = {Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders},
  journal = {Human Gene Therapy},
  year = {2023},
  doi = {10.1089/hum.2023.109}
}
Kostenlos starten →